Weight Regain

Deep dive

Weight Regain: complete reference

Weight regain after stopping a GLP-1 medication is the norm, not the exception — and reflects underlying obesity neurobiology rather than willpower failure. STEP-4 trial: patients switched from semaglutide to placebo regained 6.9% body weight over 48 weeks. STEP-1 extension: 1 year off semaglutide showed two-thirds of prior loss regained. Mechanism: when GLP-1 cleared (5-7 weeks after last dose), appetite signals return to baseline, gastric emptying speeds up, food reward signaling returns. Body actively defends pre-treatment weight через increased hunger + decreased metabolic rate. Implications: GLP-1 therapy is best framed как chronic disease management, similar to statins для cholesterol. Maintenance strategies — protein-first eating, resistance training, structured behavioral support, possibly lower-dose maintenance GLP-1 — can slow regain but rarely prevent entirely. Greater initial weight loss correlates with more rapid + greater regain. Plan for ongoing treatment OR active maintenance protocols.

In practice

You lost 30 lbs on Wegovy then stopped due to cost. Over the next 12 months, you're likely to regain ~20 lbs — that's pharmacology, not failure.

Clinical context

Obesity-as-chronic-disease framing: regain after stopping is expected. Long-term therapy or active maintenance is the standard of care.